Cannabis Law Report

OCTOBER 15, 2021

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. PAOG’s RespRx research has shown effectiveness in the treatment of Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. 9,199,960). USOTC: USMJ).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

JULY 22, 2019

million common shares of Supreme Cannabis (the “Consideration Shares”), giving the Transaction an approximate dollar value of $20,000,000 as of the Company’s closing price on July 16, 2019. The Transaction is valued at 14.7 The Transaction is valued at 14.7 ” Transaction Highlights.

Legalization 40

Legalization Research and Development Extraction Pharmaceutical 40

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘). The Valens Company Inc. (TSX:

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JUNE 1, 2021

Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Net revenue increased 37% during FY 2021 over the prior year driven by double-digit growth across Canadian cannabis, international cannabis and other consumer products businesses. Net revenue.

Data 95

Data Vaping Supply Chain Business 95